Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2015-10-19 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: QUINT-FONSEGRIVES (31130), Haute-Garonne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU CENTRE : revenue, balance sheet and financial ratios
PHARMACIE DU CENTRE is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in QUINT-FONSEGRIVES (31130),
this company of category PME
shows in 2024 a net income positive of 187 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU CENTRE (SIREN 814246955)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
186 585 €
391 962 €
173 326 €
192 784 €
164 414 €
157 501 €
169 977 €
186 496 €
139 806 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DU CENTRE generates positive net income of 187 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 140 k€ -> 187 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
186 585 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 84%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
83.871%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
47.106%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
879.891
401.279
254.823
173.772
125.569
87.184
63.898
18.904
83.871
Financial autonomy
8.645
17.164
24.933
32.302
39.319
46.924
54.309
74.114
47.106
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
83.872024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average+12 pts over 3 years
In 2024, the debt ratio of PHARMACIE DU CENTRE (83.87) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
47.11%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average-13 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU CENTRE (47.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 166.20. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
166.203
Liquidity indicators evolution PHARMACIE DU CENTRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
126.471
122.692
144.641
140.553
153.995
159.363
178.551
142.608
166.203
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
166.22024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average
In 2024, the liquidity ratio of PHARMACIE DU CENTRE (166.20) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE DU CENTRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU CENTRE is estimated at
2 604 864 €
(range 1 813 986€ - 3 897 026€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1813k€2604k€3897k€
2 604 864 €Range: 1 813 986€ - 3 897 026€
NAF 5 année 2024
Valuation method used
Net Income Multiple
186 585 €
×
14.0x
=2 604 865 €
Range: 1 813 986€ - 3 897 026€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU CENTRE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU CENTRE
What is the revenue of PHARMACIE DU CENTRE ?
The revenue of PHARMACIE DU CENTRE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DU CENTRE profitable?
Yes, PHARMACIE DU CENTRE generated a net profit of 187 k€ in 2024.
Where is the headquarters of PHARMACIE DU CENTRE ?
The headquarters of PHARMACIE DU CENTRE is located in QUINT-FONSEGRIVES (31130), in the department Haute-Garonne.
Where to find the tax return of PHARMACIE DU CENTRE ?
The tax return of PHARMACIE DU CENTRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU CENTRE operate?
PHARMACIE DU CENTRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart